As microbial cleaning products continue to gain market acceptance across homecare, industrial, institutional and pet care sectors, manufacturers are increasingly incorporating Bacillus-based additives and concentrates into their formulations.
While Bacillus spores are exceptionally robust and stable, successful manufacturing requires careful process control to maintain product viability while preventing biological carryover into subsequent production runs.
This guide outlines best practice for manufacturers using Bacillus-based ingredients, explaining how effective production sequencing, validated cleaning procedures and good manufacturing practices help maintain both product quality and manufacturing efficiency.
You can download the full guide in our Resource section
What makes Bacillus spores different?
Unlike vegetative bacteria, the Bacillus strains used in probiotic cleaning products are supplied as dormant spores.
In this dormant state, the spores are metabolically inactive and highly resistant, allowing them to withstand:
- Long-term storage
- Transportation and distribution
- Formulation and manufacturing processes
- Temperature fluctuations
- Challenging chemical environments
This exceptional resilience makes Bacillus spores ideally suited for commercial cleaning formulations, providing excellent product stability and shelf life. However, the same durability also means robust manufacturing controls are essential to prevent unintended transfer or cross-contamination into non-microbial product
Why is preventing cross-contamination important?
Cross-contamination occurs when viable Bacillus spores or vegetative cells remain within manufacturing equipment and are unintentionally transferred into a subsequent batch.
This may occur through residual product remaining in:
- blending vessels
- transfer pipework
- pumps
- filling heads
- hoses
- holding tanks
- valves
- gaskets
For preserved cleaning formulations, existing cleaning procedures often provide sufficient control. However, additional decontamination may be required when manufacturing:
- microbiologically sensitive formulations
- low-bioburden products
- unpreserved products
- products incompatible with microbial carryover
A risk-based approach allows manufacturers to determine when enhanced cleaning or validated sporicidal treatment is appropriate.
The three foundations of contamination control
Effective contamination prevention is built on three complementary principles.
1. Production sequencing
One of the simplest and most cost-effective controls is careful scheduling.
Where practical, Bacillus-containing products should be manufactured:
- after microbiologically sensitive products
- before products containing harsh disinfectants
- before formulations containing strong oxidising chemistries
Logical production sequencing reduces crossover risk before cleaning even begins.
2. Effective cleaning and equipment hygiene
Cleaning removes residual product before spores have an opportunity to remain within equipment.
Best practice includes:
- draining vessels immediately after manufacture
- rinsing before residues dry
- cleaning all product-contact surfaces
- flushing transfer lines
- cleaning filling heads and hoses
- inspecting difficult-to-clean components
Particular attention should be paid to:
- valves
- seals
- gaskets
- spray shadow zones
- dead legs
- pump housings
These locations commonly retain product residues that standard rinse procedures may miss.
3. Verification and validation
Cleaning should never rely on assumptions.
Validated cleaning programmes establish evidence that equipment consistently achieves acceptable cleanliness, while routine verification confirms each cleaning cycle meets predetermined release criteria.
Typical verification methods include:
- visual inspection
- CIP parameter review
- ATP or residue testing
- microbiological swabs
- rinse sampling
- first-off product testing
- spore-specific verification where required
Maintaining Bacillus viability during manufacturing
Preventing contamination is only half of the equation.
Manufacturers must also preserve the viability of Bacillus spores throughout blending and filling.
Because spores naturally settle during storage and transportation, liquid concentrates should always be homogenised immediately before dosing.
Suitable methods include:
- stirring
- recirculation
- controlled shaking
Following addition, mixing should continue long enough to achieve uniform distribution throughout the batch.
For many liquid concentrates, approximately 15–30 minutes provides an effective starting point, although optimum mixing will depend on vessel size, viscosity and impeller design.
Protect spores from incompatible conditions
Manufacturing conditions should minimise unnecessary exposure to:
- excessive heat
- strong oxidising agents
- incompatible preservatives
- aggressive disinfectants
- sporicidal chemistries
Where possible, formulation pH should remain within the validated compatibility range. Genesis Biosciences generally recommends a pH between 5 and 9, unless product-specific data supports wider limits.
Residual cleaning chemicals must also be completely flushed from equipment before Bacillus products are introduced, as remaining oxidants may reduce microbial viability.
Maintain homogeneity during filling
Spores may continue settling during prolonged holding periods.
Where practical, manufacturers should maintain gentle agitation or recirculation throughout filling to ensure consistent microbial counts across the entire production run.
Quality assurance should include:
- first-fill sampling
- middle-fill checks
- end-of-run verification
particularly where there is any risk of settlement.
Is standard CIP cleaning enough?
This is one of the most common questions manufacturers ask.
The answer depends entirely on the next product being manufactured.
For many routine cleaning products, a properly designed Cleaning-in-Place (CIP) programme effectively removes residues and dramatically reduces biological carryover.
However, it’s important to distinguish between cleaning and spore inactivation.
Standard detergent CIP is highly effective at removing soils and formulation residues but may not destroy dormant Bacillus spores.
Where the subsequent product is particularly sensitive, manufacturers should include a validated sporicidal decontamination step.
Routine cleaning is often sufficient, but additional sporicidal treatment may be required when changing from microbial to non-microbial production, manufacturing low-bioburden or unpreserved products, or where customer specifications require the absence of viable spores. It should also be considered when cleaning validation identifies an increased risk of cross-contamination.
A range of validated sporicidal chemistries can be used, including sodium hypochlorite, peracetic acid, hydrogen peroxide, peroxide–peracetic acid systems, and, in certain applications, glutaraldehyde. The most appropriate option should be selected based on its effectiveness, equipment compatibility, required contact time, chemical concentration, and operator safety.
An effective cleaning programme typically follows eight sequential stages:
A practical CIP workflow for Bacillus manufacturing
- Drain residual product.
- Complete an immediate pre-rinse.
- Perform detergent wash or standard CIP.
- Conduct an intermediate rinse.
- Apply validated sporicidal treatment where required.
- Carry out a final rinse.
- Drain and dry equipment under hygienic conditions.
- Verify cleaning effectiveness before product release.
Documenting every stage supports compliance while providing confidence that crossover risks remain under control.
Do manufacturers need dedicated Bacillus production equipment?
In most cases, no.
Bacillus-based products can be safely manufactured on shared equipment when supported by a robust contamination control strategy. This includes validated cleaning procedures, effective production sequencing, appropriate rinse and sanitation protocols, documented verification, and risk-based product release criteria.
Dedicated equipment is generally only necessary for highly sensitive manufacturing environments or where cleaning validation cannot demonstrate that an acceptable level of control has been achieved.
Key takeaways
Successful manufacture of Bacillus-based products relies on balancing two priorities:
- maintaining the viability of beneficial spores
- preventing unintended biological carryover
By combining risk-based production scheduling, validated cleaning programmes, careful formulation practices and robust verification procedures, manufacturers can confidently produce microbial cleaning products alongside conventional formulations using shared equipment.
As demand for sustainable microbial technologies continues to grow, implementing manufacturing best practice ensures consistent product performance, regulatory confidence and long-term manufacturing efficiency.
Frequently Asked Questions
Can Bacillus spores survive normal cleaning?
Yes. Standard cleaning removes residues extremely effectively but dormant Bacillus spores are naturally resilient. Where complete spore elimination is required, manufacturers should validate a sporicidal decontamination step.
Do preservatives kill Bacillus spores?
Not necessarily. Many preservatives inhibit germination and vegetative growth without destroying dormant spores.
Should Bacillus concentrates be mixed before use?
Yes. Spores naturally settle during storage, so concentrates should be thoroughly homogenised before dosing into production vessels.
Is a dedicated manufacturing vessel required?
Usually not. Shared vessels are generally suitable when supported by validated cleaning, production sequencing and verification procedures.
How can manufacturers demonstrate effective cleaning?
Best practice combines documented CIP parameters, visual inspection, microbiological testing, residue monitoring and first-off product verification, with spore-specific testing where appropriate.